000 01707 a2200505 4500
005 20250515094416.0
264 0 _c20080108
008 200801s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/j.transproceed.2007.09.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZakliczyński, M
245 0 0 _aThe influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy.
_h[electronic resource]
260 _bTransplantation proceedings
_cNov 2007
300 _a2866-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aCoronary Disease
_xepidemiology
650 0 4 _aCoronary Vessels
_xpathology
650 0 4 _aCytomegalovirus Infections
_xblood
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aGraft Survival
_xphysiology
650 0 4 _aHeart Transplantation
_xadverse effects
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhosphoproteins
_xblood
650 0 4 _aPostoperative Complications
_xepidemiology
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Analysis
650 0 4 _aSurvivors
650 0 4 _aTime Factors
650 0 4 _aTransplantation, Homologous
650 0 4 _aViral Matrix Proteins
_xblood
700 1 _aKrynicka-Mazurek, A
700 1 _aPyka, Ł
700 1 _aTrybunia, D
700 1 _aNadziakiewicz, P
700 1 _aPrzybylski, R
700 1 _aZembala, M
773 0 _tTransplantation proceedings
_gvol. 39
_gno. 9
_gp. 2866-9
856 4 0 _uhttps://doi.org/10.1016/j.transproceed.2007.09.013
_zAvailable from publisher's website
999 _c17538295
_d17538295